Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
Novo Nordisk, the Danish drug giant behind Ozempic, is streamlining its corporate culture and shortening its name as it tries to better compete in the market for weight-loss drugs. The company announced that it will now go by “Novo,